SEC 13F Intelligence

Lion Point Capital, LP / JSPR

Lion Point Capital, LP’s Jasper Therapeutics Inc Position

Does Lion Point Capital, LP own Jasper Therapeutics Inc (JSPR)? Yes — 465.0K shares worth $407,433 (+2.44% of its 13F portfolio) as of Q1 2026.

Position Value
$407,433
Q1 2026
Shares
465.0K
% of Portfolio
+2.44%
Quarters Held
9
currently held

Position History JSPR

Reported value by quarter
Q1 ’24: $939,520Q1 ’24Q2 ’24: $726,400Q3 ’24: $601,920Q3 ’24Q4 ’24: $684,160Q1 ’25: $629,950Q1 ’25Q2 ’25: $813,075Q3 ’25: $948,568Q3 ’25Q4 ’25: $850,950Q1 ’26: $407,433Q1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026465.0K$407,433+2.44%
Q4 2025465.0K$850,950+4.40%
Q3 2025398.6K$948,568+5.39%
Q2 2025146.5K$813,075+5.52%
Q1 2025146.5K$629,950+4.02%
Q4 202432.0K$684,160+3.58%
Q3 202432.0K$601,920+1.34%
Q2 202432.0K$726,400+1.32%
Q1 202432.0K$939,520+0.53%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lion Point Capital, LP’s full portfolio or all institutional holders of JSPR.